|
|
||||||||
1 Teijin Institute for Biomedical Research, Asahigaoka, 4-3-2, Hino-city, Tokyo 191
and2 Department of Microbiology, Miyazaki Medical College, Miyazaki, Japan
Hybridomas producing human monoclonal antibodies (MAbs) against human cytomegalovirus (CMV) were generated by fusion of human spleen cells and mouse myeloma cells. Two of the six MAbs obtained neutralized viral infectivity even at concentrations lower than 1 µg/ml. One MAb required complement for neutralization but the other did not. Both MAbs recognized viral proteins of Mr 130000 and 55000. Furthermore, these neutralizing MAbs bound to the surface membrane of CMV-infected cells. These results suggest that human MAbs may provide a new means of passive immunization against CMV infection in humans.
Keywords: CMV, human monoclonal antibodies, neutralization
Received 30 September 1986;
accepted 28 January 1987.
This article has been cited by other articles:
![]() |
J. Lantto, J. M. Fletcher, and M. Ohlin A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B J. Gen. Virol., August 1, 2002; 83(8): 2001 - 2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Klein, K. Schoppel, N. Amvrossiadis, and M. Mach Strain-Specific Neutralization of Human Cytomegalovirus Isolates by Human Sera J. Virol., February 1, 1999; 73(2): 878 - 886. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |